Back60 Degrees Pharmaceuticals- Warrants (16/05/2028) Overview
60 Degrees Pharmaceuticals Inc - Warrants (16/05/2028)

60 Degrees Pharmaceuticals- Warrants (16/05/2028) Return on Equity

Valuation check: SXTPW's ROE is -159.44%, below the sector sector average of -5.87%.

Get informed when a big investor buys or sells

+ Follow

ROE

-159.44%

Return on Equity

-159.44%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

60 Degrees Pharmaceuticals- Warrants (16/05/2028) (SXTPW) FAQ

The latest ROE for SXTPW is -159.44%. That is below the sector sector average of -5.87%. Investors often review this figure alongside 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SXTPW currently prints -159.44% for ROE, while the sector average sits near -5.87%. That is roughly 2616.9% below the sector mean. Large gaps often invite a closer look at 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s growth, margins, and balance sheet.

Return on Equity shows how effectively 60 Degrees Pharmaceuticals- Warrants (16/05/2028) converts resources into returns. At -159.44%, SXTPW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SXTPW's ROE (-159.44%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.